Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma

Ari J. Rosenberg, Nishant Agrawal, Alexander T. Pearson, Zhen Gooi, Elizabeth Blair, Louis Portugal, John F. Cursio, Aditya Juloori, Jeffrey Chin, Kathryn Rouse, Victoria M. Villaflor, Tanguy Y. Seiwert, Evgeny Izumchenko, Mark W. Lingen, Daniel J. Haraf, Everett E. Vokes

Open source

DOI: 10.1038/s41416-022-01941-0
Published: 2022-08-09
Container: British Journal of Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41416-022-01941-0,
  title = {Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma},
  author = {Ari J. Rosenberg and Nishant Agrawal and Alexander T. Pearson and Zhen Gooi and Elizabeth Blair and Louis Portugal and John F. Cursio and Aditya Juloori and Jeffrey Chin and Kathryn Rouse and Victoria M. Villaflor and Tanguy Y. Seiwert and Evgeny Izumchenko and Mark W. Lingen and Daniel J. Haraf and Everett E. Vokes},
  year = {2022},
  journal = {British Journal of Cancer},
  doi = {10.1038/s41416-022-01941-0},
  url = {https://doi.org/10.1038/s41416-022-01941-0}
}

RIS

TY  - JOUR
TI  - Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma
AU  - Ari J. Rosenberg
AU  - Nishant Agrawal
AU  - Alexander T. Pearson
AU  - Zhen Gooi
AU  - Elizabeth Blair
AU  - Louis Portugal
AU  - John F. Cursio
AU  - Aditya Juloori
AU  - Jeffrey Chin
AU  - Kathryn Rouse
AU  - Victoria M. Villaflor
AU  - Tanguy Y. Seiwert
AU  - Evgeny Izumchenko
AU  - Mark W. Lingen
AU  - Daniel J. Haraf
AU  - Everett E. Vokes
PY  - 2022
JO  - British Journal of Cancer
DO  - 10.1038/s41416-022-01941-0
UR  - https://doi.org/10.1038/s41416-022-01941-0
ER  -

APA

Rosenberg, A. J., Agrawal, N., Pearson, A. T., Gooi, Z., Blair, E., Portugal, L., Cursio, J. F., Juloori, A., Chin, J., Rouse, K., Villaflor, V. M., Seiwert, T. Y., Izumchenko, E., Lingen, M. W., Haraf, D. J., & Vokes, E. E. (2022). Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. British Journal of Cancer. https://doi.org/10.1038/s41416-022-01941-0

Source records

crossref · retrieved 2026-09-26T15:23:22.334Z